Inotersen Subcutaneous and Pioglitazone and Metformin Extended-Release Tablets
Determining the interaction of Inotersen Subcutaneous and Pioglitazone and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Pioglitazone and Metformin Tablets
- Inotersen Subcutaneous-Pioglitazone Hydrochloride
- Inotersen Subcutaneous-Pioglitazone Tablets
- Inotersen Subcutaneous-Piperacillin
- Inotersen Subcutaneous-Piperacillin and tazobactam
- Inotersen Subcutaneous-Piperacillin and tazobactam Intravenous
- Pioglitazone and Metformin Extended-Release Tablets-Inotuzumab ozogamicin
- Pioglitazone and Metformin Extended-Release Tablets-Inotuzumab ozogamicin Intravenous
- Pioglitazone and Metformin Extended-Release Tablets-Inova
- Pioglitazone and Metformin Extended-Release Tablets-Inova 4/1 topical
- Pioglitazone and Metformin Extended-Release Tablets-Inova 8/2 topical
- Pioglitazone and Metformin Extended-Release Tablets-Inova ACT